The Intermediate and Long-term Follow up of Home Based Pelvic Muscle Training

The Intermediate and Long-term Follow up of Home Based Pelvic Muscle Training : Prospective Study

When participants present with symptoms of pelvic organ prolapse (POP) and stress urinary incontinence (SUI), the investigators will perform a comprehensive evaluation and initially provide conservative treatment. If conservative treatment fails, invasive treatment will be considered. The investigators will arrange a pelvic muscle training course two to three times a week for a duration of 1.5 months per course. However, participants may complain about the inconvenience of traffic, which may lead to discontinuation of the pelvic training course. Therefore, the investigators propose the development of a home-based pelvic muscle training device and will collaborate with information engineering specialists at Tamkang University to invent the device for home-based pelvic muscle training.

Study Overview

Detailed Description

The investigators will enroll participants with SUI or POP and allocate them into either the home-based pelvic floor muscle training (PFMT) group or traditional PFMT group. Participant satisfaction will be evaluated using a questionnaire score.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taipei, Taiwan, 112
        • Recruiting
        • Taipei Veterans General Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women with SUI and Pelvic organ prolapse could be enrolled for study

Description

Inclusion Criteria:

  • Age > 18-year-old, non-pregnancy, SUI, bladder capacity > 300ml, RU<150ml, pelvic organ prolapse

Exclusion Criteria:

  • recurrent UTI, cancer patients, chronic pelvic pain, psychologic problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Home-based pelvic muscle training devices group
Patients underwent pelvic muscle training by home-based device and at home.
Performed home-based pelvic muscle training devices at home or traditional PFMT at hospital
Traditional pelvic muscle training devices group
Patients underwent traditional pelvic muscle training at hospital
Performed home-based pelvic muscle training devices at home or traditional PFMT at hospital

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The satisfication of pelvic muscle training (UDI-6)
Time Frame: up to 2 years
The total score ranges from 0 to 18, with a higher score indicating that the patient experiences a greater degree of urinary distress.
up to 2 years
The satisfication of pelvic muscle training (ICIQ-SF)
Time Frame: up to 2 years
The total score ranges from 0 to 21, with a higher score indicating that the patient experiences a greater degree of urinary distress.
up to 2 years
The satisfication of pelvic muscle training (IIQ-7)
Time Frame: up to 2 years
The total score ranges from 0 to 21, with a higher score indicating that the patient experiences a greater degree of urinary distress.
up to 2 years
The satisfication of pelvic muscle training (POPDI-6)
Time Frame: up to 2 years
POPDI-6 scores range from 0 to 24 and higher scores indicate worse bulging symptoms
up to 2 years
The satisfication of pelvic muscle training (PISQ-IR)
Time Frame: up to 2 years
The PISQ-IR is a validated questionnaire in research for assessment of female sexual function. A higher score indicates a greater negative impact on sexual function.
up to 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Huann-Cheng Horng, Taipei Veterans General Hospital, Taiwan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2023

Primary Completion (Anticipated)

December 31, 2025

Study Completion (Anticipated)

December 31, 2026

Study Registration Dates

First Submitted

February 20, 2023

First Submitted That Met QC Criteria

March 9, 2023

First Posted (Actual)

March 21, 2023

Study Record Updates

Last Update Posted (Actual)

March 21, 2023

Last Update Submitted That Met QC Criteria

March 9, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Organ Prolapse

Clinical Trials on Home-based pelvic muscle training devices or traditional PFMT at hospital

Subscribe